Ongoing measles transmission in the United States, driven by multiple active outbreaks and low vaccination coverage in affected communities, continues to push case counts higher according to Centers for Disease Control and Prevention surveillance. As of early May 2026, CDC data show 1,842 confirmed cases nationwide this year, the vast majority linked to outbreaks and occurring among unvaccinated individuals. Recent weekly additions of 20–50 cases reflect persistent community spread across more than 30 jurisdictions, with summer travel likely to introduce additional importations. Traders should monitor the CDC’s next weekly update for any acceleration or containment signals before the May 31 cutoff, as case definitions and reporting lags can influence final tallies used for market resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by May 31?
Measles cases in U.S. by May 31?
$70,090 Wol.
May 31, 2026
1900
99%
1925
97%
1950
69%
2000
14%
2200
1%
2400
1%
$70,090 Wol.
1900
$29,849 Wol.
99%
1925
$5,462 Wol.
97%
1950
$11,875 Wol.
69%
2000
$14,274 Wol.
14%
2200
$2,893 Wol.
1%
2400
$955 Wol.
1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by multiple active outbreaks and low vaccination coverage in affected communities, continues to push case counts higher according to Centers for Disease Control and Prevention surveillance. As of early May 2026, CDC data show 1,842 confirmed cases nationwide this year, the vast majority linked to outbreaks and occurring among unvaccinated individuals. Recent weekly additions of 20–50 cases reflect persistent community spread across more than 30 jurisdictions, with summer travel likely to introduce additional importations. Traders should monitor the CDC’s next weekly update for any acceleration or containment signals before the May 31 cutoff, as case definitions and reporting lags can influence final tallies used for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Apr 28, 2026, 6:09 PM ET
Wolumen
$70,090Data zakończenia
May 31, 2026Rynek otwarty
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by multiple active outbreaks and low vaccination coverage in affected communities, continues to push case counts higher according to Centers for Disease Control and Prevention surveillance. As of early May 2026, CDC data show 1,842 confirmed cases nationwide this year, the vast majority linked to outbreaks and occurring among unvaccinated individuals. Recent weekly additions of 20–50 cases reflect persistent community spread across more than 30 jurisdictions, with summer travel likely to introduce additional importations. Traders should monitor the CDC’s next weekly update for any acceleration or containment signals before the May 31 cutoff, as case definitions and reporting lags can influence final tallies used for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$70,090Data zakończenia
May 31, 2026Rynek otwarty
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...Ongoing measles transmission in the United States, driven by multiple active outbreaks and low vaccination coverage in affected communities, continues to push case counts higher according to Centers for Disease Control and Prevention surveillance. As of early May 2026, CDC data show 1,842 confirmed cases nationwide this year, the vast majority linked to outbreaks and occurring among unvaccinated individuals. Recent weekly additions of 20–50 cases reflect persistent community spread across more than 30 jurisdictions, with summer travel likely to introduce additional importations. Traders should monitor the CDC’s next weekly update for any acceleration or containment signals before the May 31 cutoff, as case definitions and reporting lags can influence final tallies used for market resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania